Functional and Structural Alterations of Cardiac and Skeletal Muscle Mitochondria in Heart Failure Patients

Archives of Medical Research

Volumn 45, Issue 3, 2014, Pages 237-246

  Guzmán Mentesana, Gustavo ^a   Báez, Alejandra L ^a   Lo Presti, María S ^a   Domínguez, Ricardo ^b   Córdoba, Roque ^c   Bazán, Carolina ^a   Strauss, Mariana ^a   Fretes, Ricardo ^d   Rivarola, Héctor W ^a   Paglini Oliva, Patricia ^a  

^a Centro de Investigaciones En Quimica Biologica de Cordoba   (Argentina)

^b Servicio de Neurología   (Argentina)

^c Allende Clinic   (Argentina)

^d FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Cardiac and skeletal muscle; Heart failure; Mitochondria

Indexed keywords

3 NITROTYROSINE; INDUCIBLE NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; UBIQUINOL CYTOCHROME C REDUCTASE;

ADULT; ARTICLE; CARDIOVASCULAR SURGERY; CELL ISOLATION; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FRAMINGHAM RISK SCORE; HEART FAILURE; HEART LEFT VENTRICLE; HEART MITOCHONDRION; HEART MUSCLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MITOCHONDRIAL RESPIRATION; MOLECULAR EVOLUTION; MUSCLE BIOPSY; MUSCLE MITOCHONDRION; PECTORAL MUSCLE; PROTEIN EXPRESSION; SKELETAL MUSCLE; SPECTROPHOTOMETRY;

CARDIAC AND SKELETAL MUSCLE; HEART FAILURE; MITOCHONDRIA;

AGED; CASE-CONTROL STUDIES; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; MYOCARDIUM; REACTIVE OXYGEN SPECIES;

EID: 84899529133     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2014.03.003     Document Type: Article

References (26)

1. World Health Organization: Cardiovascular diseases. Geneva;2007.
2. Borlaug B.A., Paulus W.J. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J 2011, 32:670-679.
3. Tsutsui H., Kinugawa S., Matsushima S. Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovascular Res 2009, 81:449-456.
4. Marin-Garcia J., Goldenthal M.J. Mitochondrial centrality in heart failure. Heart Fail Rev 2008, 13:137-150.
5. Marín-García J., Akhmedov A.T., Moe G.W. Mitochondria in heart failure: the emerging role of mitochondrial dynamics. Heart Failure 2013, 18:439-456.
6. Tsutsui H. Novel pathophysiological insights and treatment strategies for heart failure-lessons from mice and patients. Circ J 2004, 68:1095-1113.
7. Tsutsui H. Mitochondrial oxidative stress and heart failure. Intern Med 2006, 45:809-813.
8. Marin-Garcia J., Pi Y., Goldenthal M.J. Mitochondrial-nuclear cross-talk in the aging and failing heart. Cardiovasc Drugs Ther 2006, 20:477-491.
9. Marin-Garcia J., Goldenthal M.J. The mitochondrial organelle and the heart. Rev Esp Cardiol 2002, 55:1293-1310.
10. Baez A., Lo Presti S., Rivarola W., et al. Trypanosoma cruzi: mitochondrial alterations produced by two different strain in the acute phase of the infection. Exp Parasitol 2008, 120:397-402.
11. Baez A., Lo Presti M.S., Rivarola H.W., et al. Mitochondrial involvement in the chronic chagasic cardiomyopathy. Trans R Soc Trop Med and Hyg 2011, 105:239-246.
12. Baez A., Lo Presti M.S., Rivarola H.W., et al. Chronic indeterminate phase of Chagas' disease: mitochondrial involvement in infection with two strains. Parasitology 2013, 140:414-421.
13. Trounce I.A., Kim Y.L., Jun A.S., et al. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 1996, 264:484-509.
14. Jarreta D., Orus J., Barrientos A., et al. Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovasc Res 2000, 45:860-865.
15. Vyatkina G., Bhatia V., Gerstner A., et al. Impaired mitochondrial respiratory chain and bioenergetics during chagasic cardiomyopathy development. Biochim Biophys Acta 2004, 1689:162-173.
16. Bradford M.A. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-DNA binding. Annal Biochem 1976, 72:248-254.
17. Kuzmicic J., Del Campo A., López-Crisosto C., et al. Mitochondrial dynamics: a potential new therapeutic target for heart failure. Rev Esp Cardiol 2011, 64:916-923.
18. Starling R.C., Hammer D.F., Altschuld R.A. Human myocardial ATP content and invivo contractile function. Mol Cell Biochem 1998, 180:171-177.
19. Beer M., Seyfarth T., Sandstede J., et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31) P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol 2002, 40:1267-1274.
20. Sullivan M.J., Green H.J., Cobb F.R. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990, 81:518-527.
21. Nishiyama Y., Ikeda H., Haramaki N., et al. Oxidative stress is related to exercise intolerance in patients with heart failure. Am Heart J 1998, 135:115-120.
22. Wilson J.R. Exercise intolerance in heart failure. Importance of skeletal muscle. Circulation 1995, 91:559-561.
23. Tsutsui H., Ide T., Hayashidani S., et al. Enhanced generation of reactive oxygen species in the limb skeletal muscles from a murine infarct model of heart failure. Circulation 2001, 104:134-136.
24. Garnier A., Fortin D., Delomenie C., et al. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol 2003, 551:491-501.
25. Kinugawa S., Wang Z., Kaminski P.M., et al. Limited exercise capacity in heterozygous manganese superoxide dismutase gene-knockout mice: roles of superoxide anion and nitric oxide. Circulation 2005, 111:1480-1486.
26. Palaniyandi S.S., Qi X., Yogalingam G., et al. Regulation of mitochondrial processes: a target for heart failure. Drug Discov Today Dis Mech 2010, 7:e95-e102.